Related Experiment Video
Updated: Dec 28, 2025

06:09
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
9.3K
Build-a-Mouse: Melanoma Modeling Picks up Speed.
Andres Thorkelsson1, Glenn Merlino1, Helen Michael2
1Laboratory of Cancer Biology and Genetics, Center for Cancer Research, NCI, Bethesda, Maryland.
Cancer Research
|February 16, 2020
Summary
Researchers developed a faster way to create genetically engineered mouse models (GEMM) for melanoma research. This new method uses existing models to rapidly generate advanced chimeric GEMM, potentially revolutionizing melanoma studies.
Area of Science:
- Oncology
- Genetics
- Animal Models
Background:
- Genetically engineered mouse models (GEMM) are vital for melanoma research, aiding in understanding tumor initiation and therapy testing.
- Current methods for creating GEMM are time-consuming, limiting their rapid application in research.
Purpose of the Study:
- To introduce a novel and accelerated paradigm for generating advanced mouse models for melanoma research.
- To validate the efficacy of a new method for creating high-contribution chimeric GEMM.
Main Methods:
- The study utilized existing common melanoma GEMMs as a foundation.
- CRISPR, Cre-inducible, and Dox-inducible alleles were incorporated into the models.
- High-contribution chimeric GEMM were generated and validated.
Main Results:
- A rapid method for generating novel melanoma mouse models was successfully developed and validated.
- The new approach allows for the efficient creation of advanced GEMM with specific genetic modifications.
- The generated chimeric models demonstrated high contribution, indicating their utility.
Conclusions:
- The developed method offers a significant advancement in the speed and efficiency of creating melanoma GEMM.
- This innovative approach has the potential to revolutionize the field of mouse modeling for melanoma research.
- The study provides a valuable tool for accelerating discoveries in melanoma biology and therapy development.

